Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050440
Status:
COMPLETED
Last Update Posted:
2013-01-08
First Post:
2002-12-09
Brief Title:
Phase 2 Study of ET-743 Trabectedin in Patients With Persistent or Recurrent Endometrial Carcinoma
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-07
Completion Date Type:
ACTUAL
First Submit Date:
2002-12-09
First Submit QC Date:
December 9 2002
Study First Post Date:
2002-12-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-07
Last Update Post Date:
2013-01-08
Last Update Post Date Type:
ESTIMATED